Advertisement

Prevention of Typhoid Fever by Single-Dose Capsular Polysaccharide Vaccination — 2-Year Results

  • K. P. Klugman
  • H. Vosloo
  • L. Arntzen
  • H. J. Koornhof

Abstract

Typhoid fever is endemic in the tropical areas of Central and South America, Asia and Africa. While the prevalence of disease has been greatly reduced in first world countries [8] largely due to the development of protected water supplies and sewerage disposal systems, the provision of these basic facilities is rare in third world countries, and the prevention of typhoid fever by these means is not an immediate prospect. Typhoid vaccination is therefore an important way to prevent this disease in both travellers to these endemic areas and the local population themselves.

Keywords

Typhoid Fever Capsular Polysaccharide Polysaccharide Vaccine Typhoid Vaccine Sewerage Disposal System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Acharya IL, Lowe CV, Thapa R et al. (1987) Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N Engl J Med 317:1101–1104PubMedCrossRefGoogle Scholar
  2. 2.
    Bodhidatta L, Taylor DN, Thisyakorn V, Echeverria P (1987) Control of typhoid fever in Bangkok, Thailand, by annual immunization of school children with parenteral typhoid vaccine. Rev Infect Dis 9:841–845PubMedCrossRefGoogle Scholar
  3. 3.
    Felix A, Pitt RM (1934) A new antigen of B. typhosus. Its relation to virulence and to active and passive immunization. Lancet 11:186–191CrossRefGoogle Scholar
  4. 4.
    Felix A, Pitt RM (1951) The pathogenic and immunogenic activities of Salmonella typhi in relation to its antigenic constituents. J Hyg 49:92–110CrossRefGoogle Scholar
  5. 5.
    Grifiss JM, Apicella MA, Greenwood B, Makela PH (1987) Vaccines against encapsulated bacteria. Rev Infect Dis 9:176–188CrossRefGoogle Scholar
  6. 6.
    Hirschel B (1983) Failure with oral typhoid vaccine Ty 21a. Lancet 1:817–818PubMedCrossRefGoogle Scholar
  7. 7.
    Hirschel B, Wüthrich R, Somaini B, Steffen R (1985) Inefficacy of the commercial live oral Ty21a vaccine in the prevention of typhoid fever. Eur J Clin Microbiol 4:295–298PubMedCrossRefGoogle Scholar
  8. 8.
    Hornick RB (1985) Selective primary health care: strategies for control of disease in the developing world. X. Typhoid fever. Rev Infect Dis 7:536–546PubMedCrossRefGoogle Scholar
  9. 9.
    Hornick RB, Woodward TE, McCrumb FR et al. (1967) Typhoid fever vaccine -yes or no? Med Clin North Am 51:617–623PubMedGoogle Scholar
  10. 10.
    Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ (1970) Typhoid fever: pathogenesis and immunological control. N Engl J Med 283:686–691PubMedCrossRefGoogle Scholar
  11. 11.
    Klugman KP, Gilbertson IT, Koornhof HJ et al. (1987) Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 11:1165–1169CrossRefGoogle Scholar
  12. 12.
    Levine MM, Ferreccio C, Black RE, Germanier R, Chilean Typhoid Committee (1987) Large scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1:1049–1052PubMedCrossRefGoogle Scholar
  13. 13.
    Robbins JD, Robbins JB (1984) Re-examination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 150:436–449PubMedCrossRefGoogle Scholar
  14. 14.
    Tackett CO, Ferreccio C, Robbins JB et al. (1986) Safety and immunogenicity of the Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis 154:342–345CrossRefGoogle Scholar
  15. 15.
    Tapa S, Cvjetanovic B (1975) Controlled field trial on the effectiveness of one and two doses of active acetone-inactivated dried typhoid vaccine. Bull WHO 52:75–80PubMedGoogle Scholar
  16. 16.
    Wahdan MH, Serie C, Cerisier Y, Sallam S, Germanier R (1982) A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: Three-year results. J Infect Dis 145:292–295PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • K. P. Klugman
  • H. Vosloo
  • L. Arntzen
  • H. J. Koornhof

There are no affiliations available

Personalised recommendations